J Korean Assoc Oral Maxillofac Surg.  2025 Jan;51(1):67-68. 10.5125/jkaoms.2025.51.1.67.

Comment on: Efficacy of dextrose prolotherapy on temporomandibular disorder

• Merchant YP

• KMID: 2565641
• DOI: http://doi.org/10.5125/jkaoms.2025.51.1.67

Reference

References

1. Park JS, Ku JK, Kim YK, Yun PY. 2024; Efficacy of dextrose prolotherapy on temporomandibular disorder: a retrospective study. J Korean Assoc Oral Maxillofac Surg. 50:259–64. https://doi.org/10.5125/jkaoms.2024.50.5.259. DOI: 10.5125/jkaoms.2024.50.5.259. PMID: 39482101. PMCID: PMC11535124.

2. Reeves KD, Sit RW, Rabago DP. 2016; Dextrose prolotherapy: a narrative review of basic science, clinical research, and best treatment recommendations. Phys Med Rehabil Clin N Am. 27:783–823. https://doi.org/10.1016/j.pmr.2016.06.001. DOI: 10.1016/j.pmr.2016.06.001. PMID: 27788902.

3. Asan CY, Ağyüz G, Canpolat DG, Demirbas AE, Asan M, Yay A, et al. 2022; Chondrotoxic effects of intra-articular injection of local anaesthetics in the rabbit temporomandibular joint. Int J Oral Maxillofac Surg. 51:1337–44. https://doi.org/10.1016/j.ijom.2022.01.011. DOI: 10.1016/j.ijom.2022.01.011. PMID: 35120788.

4. Lubecka K, Chęcińska K, Bliźniak F, Chęciński M, Turosz N, Michcik A, et al. 2023; Intra-articular local anesthetics in temporomandibular disorders: a systematic review and meta-analysis. J Clin Med. 13:106. https://doi.org/10.3390/jcm13010106. DOI: 10.3390/jcm13010106. PMID: 38202113. PMCID: PMC10779637.

5. Sit RW, Reeves KD, Zhong CC, Wong CHL, Wang B, Chung VC, et al. 2021; Efficacy of hypertonic dextrose injection (prolotherapy) in temporomandibular joint dysfunction: a systematic review and meta-analysis. Sci Rep. 11:14638. https://doi.org/10.1038/s41598-021-94119-2. DOI: 10.1038/s41598-021-94119-2. PMID: 34282199. PMCID: PMC8289855.